Cargando…

3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk

BACKGROUND: Genome-wide association studies (GWAS) have enabled the discovery of single nucleotide polymorphisms (SNPs) that are significantly associated with many autoimmune diseases including type 1 diabetes (T1D). However, many of the identified variants lie in non-coding regions, limiting the id...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ning, Sadlon, Timothy, Wong, Ying Y., Pederson, Stephen, Breen, James, Barry, Simon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244893/
https://www.ncbi.nlm.nih.gov/pubmed/35773720
http://dx.doi.org/10.1186/s13072-022-00456-5
_version_ 1784738624533692416
author Liu, Ning
Sadlon, Timothy
Wong, Ying Y.
Pederson, Stephen
Breen, James
Barry, Simon C.
author_facet Liu, Ning
Sadlon, Timothy
Wong, Ying Y.
Pederson, Stephen
Breen, James
Barry, Simon C.
author_sort Liu, Ning
collection PubMed
description BACKGROUND: Genome-wide association studies (GWAS) have enabled the discovery of single nucleotide polymorphisms (SNPs) that are significantly associated with many autoimmune diseases including type 1 diabetes (T1D). However, many of the identified variants lie in non-coding regions, limiting the identification of mechanisms that contribute to autoimmune disease progression. To address this problem, we developed a variant filtering workflow called 3DFAACTS-SNP to link genetic variants to target genes in a cell-specific manner. Here, we use 3DFAACTS-SNP to identify candidate SNPs and target genes associated with the loss of immune tolerance in regulatory T cells (Treg) in T1D. RESULTS: Using 3DFAACTS-SNP, we identified from a list of 1228 previously fine-mapped variants, 36 SNPs with plausible Treg-specific mechanisms of action. The integration of cell type-specific chromosome conformation capture data in 3DFAACTS-SNP identified 266 regulatory regions and 47 candidate target genes that interact with these variant-containing regions in Treg cells. We further demonstrated the utility of the workflow by applying it to three other SNP autoimmune datasets, identifying 16 Treg-centric candidate variants and 60 interacting genes. Finally, we demonstrate the broad utility of 3DFAACTS-SNP for functional annotation of all known common (> 10% allele frequency) variants from the Genome Aggregation Database (gnomAD). We identified 9376 candidate variants and 4968 candidate target genes, generating a list of potential sites for future T1D or other autoimmune disease research. CONCLUSIONS: We demonstrate that it is possible to further prioritise variants that contribute to T1D based on regulatory function, and illustrate the power of using cell type-specific multi-omics datasets to determine disease mechanisms. Our workflow can be customised to any cell type for which the individual datasets for functional annotation have been generated, giving broad applicability and utility. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13072-022-00456-5.
format Online
Article
Text
id pubmed-9244893
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92448932022-06-30 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk Liu, Ning Sadlon, Timothy Wong, Ying Y. Pederson, Stephen Breen, James Barry, Simon C. Epigenetics Chromatin Research BACKGROUND: Genome-wide association studies (GWAS) have enabled the discovery of single nucleotide polymorphisms (SNPs) that are significantly associated with many autoimmune diseases including type 1 diabetes (T1D). However, many of the identified variants lie in non-coding regions, limiting the identification of mechanisms that contribute to autoimmune disease progression. To address this problem, we developed a variant filtering workflow called 3DFAACTS-SNP to link genetic variants to target genes in a cell-specific manner. Here, we use 3DFAACTS-SNP to identify candidate SNPs and target genes associated with the loss of immune tolerance in regulatory T cells (Treg) in T1D. RESULTS: Using 3DFAACTS-SNP, we identified from a list of 1228 previously fine-mapped variants, 36 SNPs with plausible Treg-specific mechanisms of action. The integration of cell type-specific chromosome conformation capture data in 3DFAACTS-SNP identified 266 regulatory regions and 47 candidate target genes that interact with these variant-containing regions in Treg cells. We further demonstrated the utility of the workflow by applying it to three other SNP autoimmune datasets, identifying 16 Treg-centric candidate variants and 60 interacting genes. Finally, we demonstrate the broad utility of 3DFAACTS-SNP for functional annotation of all known common (> 10% allele frequency) variants from the Genome Aggregation Database (gnomAD). We identified 9376 candidate variants and 4968 candidate target genes, generating a list of potential sites for future T1D or other autoimmune disease research. CONCLUSIONS: We demonstrate that it is possible to further prioritise variants that contribute to T1D based on regulatory function, and illustrate the power of using cell type-specific multi-omics datasets to determine disease mechanisms. Our workflow can be customised to any cell type for which the individual datasets for functional annotation have been generated, giving broad applicability and utility. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13072-022-00456-5. BioMed Central 2022-06-30 /pmc/articles/PMC9244893/ /pubmed/35773720 http://dx.doi.org/10.1186/s13072-022-00456-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Ning
Sadlon, Timothy
Wong, Ying Y.
Pederson, Stephen
Breen, James
Barry, Simon C.
3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title_full 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title_fullStr 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title_full_unstemmed 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title_short 3DFAACTS-SNP: using regulatory T cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (T1D) risk
title_sort 3dfaacts-snp: using regulatory t cell-specific epigenomics data to uncover candidate mechanisms of type 1 diabetes (t1d) risk
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244893/
https://www.ncbi.nlm.nih.gov/pubmed/35773720
http://dx.doi.org/10.1186/s13072-022-00456-5
work_keys_str_mv AT liuning 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk
AT sadlontimothy 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk
AT wongyingy 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk
AT pedersonstephen 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk
AT breenjames 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk
AT barrysimonc 3dfaactssnpusingregulatorytcellspecificepigenomicsdatatouncovercandidatemechanismsoftype1diabetest1drisk